Cargando…

Different accelerated corneal collagen cross-linking treatment modalities in progressive keratoconus

BACKGROUND: To compare the outcomes of two different protocols of accelerated corneal crosslinking (CXL) on visual, corneal high order aberrations (HOA) and topographic parameters in patients with progressive keratoconus. METHODS: In this prospective comparative study, sixty-six eyes of 66 patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Kirgiz, Ahmet, Eliacik, Mustafa, Yildirim, Yusuf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6545739/
https://www.ncbi.nlm.nih.gov/pubmed/31172016
http://dx.doi.org/10.1186/s40662-019-0141-6
_version_ 1783423434585276416
author Kirgiz, Ahmet
Eliacik, Mustafa
Yildirim, Yusuf
author_facet Kirgiz, Ahmet
Eliacik, Mustafa
Yildirim, Yusuf
author_sort Kirgiz, Ahmet
collection PubMed
description BACKGROUND: To compare the outcomes of two different protocols of accelerated corneal crosslinking (CXL) on visual, corneal high order aberrations (HOA) and topographic parameters in patients with progressive keratoconus. METHODS: In this prospective comparative study, sixty-six eyes of 66 patients with progressive keratoconus were divided into two groups; 37 eyes in Group 1 received 18 mW/cm(2) for five minutes, and 29 eyes in Group 2 were treated with 9 mW/cm(2) for 10 min. The uncorrected distant visual acuity (UCVA), best-corrected distant visual acuity (BCVA), corneal HOAs and topography parameters were measured preoperatively and postoperatively at the end of 12 months. The data for the two groups were compared statistically. RESULTS: The mean UCVA and BCVA were significantly improved at the postoperative 12 months compared with the preoperative values in both groups (P < 0.05 for all). A significant improvement in corneal HOAs was observed in both groups (P < 0.05 for all). The change in corneal coma value was significantly higher in Group 2 (P < 0.05). The change in keratometric values K1, K2, AvgK and maximum keratometry (AKf) were significantly higher in Group 2 (P < 0.05 for all). The regression model showed that the most important factor predicting the change in AKf was the type of CXL (β = − 0.482, P = 0.005). CONCLUSIONS: Accelerated CXL using 10 min of UVA irradiance at 9 mW/cm(2) showed better topographic improvements and coma values than five minutes of UVA irradiance at 18 mW/cm(2) independent of keratoconus severity.
format Online
Article
Text
id pubmed-6545739
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-65457392019-06-06 Different accelerated corneal collagen cross-linking treatment modalities in progressive keratoconus Kirgiz, Ahmet Eliacik, Mustafa Yildirim, Yusuf Eye Vis (Lond) Research BACKGROUND: To compare the outcomes of two different protocols of accelerated corneal crosslinking (CXL) on visual, corneal high order aberrations (HOA) and topographic parameters in patients with progressive keratoconus. METHODS: In this prospective comparative study, sixty-six eyes of 66 patients with progressive keratoconus were divided into two groups; 37 eyes in Group 1 received 18 mW/cm(2) for five minutes, and 29 eyes in Group 2 were treated with 9 mW/cm(2) for 10 min. The uncorrected distant visual acuity (UCVA), best-corrected distant visual acuity (BCVA), corneal HOAs and topography parameters were measured preoperatively and postoperatively at the end of 12 months. The data for the two groups were compared statistically. RESULTS: The mean UCVA and BCVA were significantly improved at the postoperative 12 months compared with the preoperative values in both groups (P < 0.05 for all). A significant improvement in corneal HOAs was observed in both groups (P < 0.05 for all). The change in corneal coma value was significantly higher in Group 2 (P < 0.05). The change in keratometric values K1, K2, AvgK and maximum keratometry (AKf) were significantly higher in Group 2 (P < 0.05 for all). The regression model showed that the most important factor predicting the change in AKf was the type of CXL (β = − 0.482, P = 0.005). CONCLUSIONS: Accelerated CXL using 10 min of UVA irradiance at 9 mW/cm(2) showed better topographic improvements and coma values than five minutes of UVA irradiance at 18 mW/cm(2) independent of keratoconus severity. BioMed Central 2019-06-03 /pmc/articles/PMC6545739/ /pubmed/31172016 http://dx.doi.org/10.1186/s40662-019-0141-6 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Kirgiz, Ahmet
Eliacik, Mustafa
Yildirim, Yusuf
Different accelerated corneal collagen cross-linking treatment modalities in progressive keratoconus
title Different accelerated corneal collagen cross-linking treatment modalities in progressive keratoconus
title_full Different accelerated corneal collagen cross-linking treatment modalities in progressive keratoconus
title_fullStr Different accelerated corneal collagen cross-linking treatment modalities in progressive keratoconus
title_full_unstemmed Different accelerated corneal collagen cross-linking treatment modalities in progressive keratoconus
title_short Different accelerated corneal collagen cross-linking treatment modalities in progressive keratoconus
title_sort different accelerated corneal collagen cross-linking treatment modalities in progressive keratoconus
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6545739/
https://www.ncbi.nlm.nih.gov/pubmed/31172016
http://dx.doi.org/10.1186/s40662-019-0141-6
work_keys_str_mv AT kirgizahmet differentacceleratedcornealcollagencrosslinkingtreatmentmodalitiesinprogressivekeratoconus
AT eliacikmustafa differentacceleratedcornealcollagencrosslinkingtreatmentmodalitiesinprogressivekeratoconus
AT yildirimyusuf differentacceleratedcornealcollagencrosslinkingtreatmentmodalitiesinprogressivekeratoconus